CNC has been in
investors' good books owing to its prudent operating performance,
strong inorganic growth and solid fundamentals. A solid guidance is
another highlight of the stock.
The stock carries a
Score of A. Here V stands for Value, G for Growth and M for
Momentum with the score being a weighted combination of all the
Year to date, shares of the health insurer have gained 1.6%,
industry's growth of 31.2%. However, given its solid
fundamentals, it is expected to bounce back going forward.
The second quarter witnessed better revenues, led by the
recent PANTHERx buyout, membership growth in the Medicare business
and the continuing suspension of Medicaid eligibility
Concurrent with June-quarter results, the presently Zacks
Rank #3 (Hold) company revised its full-year outlook. You can see
the complete list of today's
For the current year, management anticipates revenues in the
still expected to be
The leading health insurer has been witnessing solid revenue
growth since 2002. In the first six months, its top line increased
13.8% year over year owing to the PANTHERx buyout, Medicaid
membership growth and a strong membership rise in the Medicare
fastest-growing specialty pharmacies in
buyout solidifies its foothold in the booming specialty drug
The leading insurer also entered into an agreement to buy
enable it to establish a behavioral health platform. Given the
current demand uptrend for behavioural health, this is the right
time for such a strategic move. The company also completed the
buyout of the remainder of
This clearly shows the company's constant efforts in
strengthening its international portfolio.
On the back of several contract wins, medical membership of
the company is steadily rising. In 2020 and during the first half
of 2021, the same rose 67% and 3% year over year, respectively. As
up 3% year over year.
Last month, Buckeye Health Plan, the company's
received a Medicaid contract from the
Care Financing and Policy.
With several contracts in the pipeline, we expect this trend
However, the company's Marketplace business has been
suffering for quite some time now. Membership in the
months of 2021.
The company's 2021 earnings estimate indicates an upside of
2.8% from the prior-year reported figure.
Time to Invest in Legal Marijuana
If you're looking for big gains, there couldn't be a better time
to get in on a young industry primed to skyrocket from
After a clean sweep of 6 election referendums in 5 states, pot
is now legal in 36 states plus D.C. Federal legalization is
expected soon and that could be a still greater bonanza for
investors. Even before the latest wave of legalization,
high as +285.9%.
You're invited to check out
An Investor's Guide. It features a timely
pot stocks and ETFs with exceptional growth potential.
Want the latest recommendations from
Click to get this free report